Ferrari N.V. (NYSE: RACE) is expected to release Q2
earnings on August 2 with earnings-per-share estimates of
$0.45 and revenue of $767.22 million.
UBS's Take
UBS's Michael Binetti commented on Ferrari's positive outlook, previewing earnings. After positive analysis, Binetti reiterated
the automotive company's Buy rating and $50.00 price target.
Can Ferrari Defy Market Conditions Again?
Binetti believed Ferrari's future earnings reports would act as a "thesis stress test" for Ferari. "RACE's car shipments
declined by less than 5 percent vs luxury auto peers' shipments down over 30 percent in the same period… and the model is about to
be tested [again]," said the UBS analyst.
Related Link: Ferrari Now A
Strong Buy, Vetr Top Raters Says
The analyst was seeing "sluggish spending" in global luxury categories; however, Binetti's recent conversations with Ferrari
management instilled confidence in the company's ability to continue its "strong" new car innovation initiatives and positive
margin drivers' growth.
"RACE deserves to trade in line with global luxury peers due to high visibility into revs & cash flows as most products are
pre-sold to wealthy consumers via long waitlists," stated Binetti.
According to TipRanks, Michael Binetti is one of the better analyst's covering Ferrari with a 56 percent success rate and a +6.4
percent average return per recommendation. The analyst is ranked 572 out of 4087 analysts.
At time of writing, Ferrari traded at $44.78, up 1.34 percent Friday.
Full ratings
data available on Benzinga Pro.
Do you have ideas for articles/interviews you'd like to see more of on Benzinga? Please email feedback@benzinga.com with your best article ideas. One person will be randomly selected to win
a $20 Amazon gift card!
Latest Ratings for RACE
Date |
Firm |
Action |
From |
To |
Apr 2016 |
JP Morgan |
Maintains |
|
Neutral |
Feb 2016 |
Banca Akros |
Initiates Coverage on |
|
Buy |
Jan 2016 |
Citigroup |
Initiates Coverage on |
|
Neutral |
View More Analyst Ratings for
RACE
View the Latest Analyst Ratings
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.